AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 278: H1874-H1882, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sambandam, N.
Right arrow Articles by Rodrigues, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sambandam, N.
Right arrow Articles by Rodrigues, B.
Vol. 278, Issue 6, H1874-H1882, June 2000

Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts

Nandakumar Sambandam, Mohammed A. Abrahani, Scott Craig, Osama Al-Atar, Esther Jeon, and Brian Rodrigues

Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3

In streptozotocin (STZ)-induced diabetic rats, we previously showed an increased heparin-releasable (luminal) lipoprotein lipase (LPL) activity from perfused hearts. To study the effect of this enlarged LPL pool on triglyceride (TG)-rich lipoproteins, we examined the metabolism of very-low-density lipoprotein (VLDL) perfused through control and diabetic hearts. Diabetic rats had elevated TG levels compared with control. However, fasting for 16 h abolished this difference. When the plasma lipoprotein fraction of density <1.006 g/ml from fasted control and diabetic rats was incubated in vitro with purified bovine or rat LPL, VLDL from diabetic animals was hydrolyzed as proficiently as VLDL from control animals. Post-heparin plasma lipolytic activity was comparable in control and diabetic animals. However, perfusion of control and diabetic rats with heparinase indicated that diabetic hearts had larger amounts of LPL bound to heparan sulfate proteoglycan-binding sites. [3H]VLDL obtained from control rats, when recirculated through the isolated heart, disappeared at a significantly faster rate from diabetic than from control rat hearts. This increased VLDL-TG hydrolysis was essentially abolished by prior perfusion of the diabetic heart with heparin, implicating LPL in this process. These findings suggest that the enlarged LPL pool in the diabetic heart is present at a functionally relevant location (at the capillary lumen) and is capable of hydrolyzing VLDL. This could increase the delivery of free fatty acid to the heart, and the resultant metabolic changes could induce the subsequent cardiomyopathy that is observed in the chronic diabetic rat.

lipoprotein lipase; diabetes; very-low-density lipoprotein


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
F. Wang, M. S. Kim, P. Puthanveetil, G. Kewalramani, S. Deppe, S. Ghosh, A. Abrahani, and B. Rodrigues
Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1108 - H1116.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
Y.-G. Niu and R. D. Evans
Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1106 - E1116.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. S. Kim, F. Wang, P. Puthanveetil, G. Kewalramani, E. Hosseini-Beheshti, N. Ng, Y. Wang, U. Kumar, S. Innis, C. G. Proud, et al.
Protein Kinase D Is a Key Regulator of Cardiomyocyte Lipoprotein Lipase Secretion After Diabetes
Circ. Res., August 1, 2008; 103(3): 252 - 260.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. Qi, D. An, G. Kewalramani, Y. Qi, T. Pulinilkunnil, A. Abrahani, U. Al-Atar, S. Ghosh, R. B. Wambolt, M. F. Allard, et al.
Altered cardiac fatty acid composition and utilization following dexamethasone-induced insulin resistance
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E420 - E427.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Pulinilkunnil and B. Rodrigues
Cardiac lipoprotein lipase: Metabolic basis for diabetic heart disease
Cardiovasc Res, February 1, 2006; 69(2): 329 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
X. Cheng, X. S. Cheng, K.-H. Kuo, and C. C.Y. Pang
Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes
Cardiovasc Res, November 1, 2004; 64(2): 298 - 307.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
Y.-G. Niu, D. Hauton, and R. D. Evans
Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates
J. Physiol., July 1, 2004; 558(1): 225 - 237.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online